A drug used to treat enlarged prostate may also be able to slow the progression of Parkinson’s disease. The surprising finding, published Sept. 16 online in The Journal of Clinical Investigation, is the result of an international collaboration involving researchers in China and at the University of Iowa that combines basic molecular biology with big data. (read more)